N'ime afọ ndị na-adịbeghị anya, ụlọ ọrụ nyocha nke in vitro (IVD) na-eto ngwa ngwa. Dị ka data wepụtara site Evaluate MedTech, site na 2014 ruo 2017, ụwa ahịa ahịa ọnụ ọgụgụ nke IVD ụlọ ọrụ amụbawo kwa afọ, site na $49 ijeri 900 nde na 2014 ruo $52 ijeri 600 nde na 2017, na-enwe kwa afọ composite ibu ọnụego. 1.8%; na 2024, ahịa ahịa ọnụ ọgụgụ na-atụ anya iru $79 ijeri 600 nde, site na 2017 ruo 2024 The compound kwa afọ uto ọnụego ruru 6.1%. N'okwu a, mkpa ụlọ ọgwụ na-abawanye na ụkpụrụ ngwa ngwa ụlọ ọrụ na-ebutekwa ihe ọhụrụ achọrọ maka ngwaahịa na teknụzụ IVD. Mgbe afọ iri nke onwe mmepe nke "Lica ìhè-induced chemiluminescence technology", dị ka a ọhụrụ chemiluminescent immunoassay usoro, Kemei nchoputa creatively adopts homogeneous mmeghachi omume usoro na nano elu-tech ahụ, na-enye ihe ngwọta ọhụrụ maka ọtụtụ ụlọ nyocha ụlọ ọgwụ. Dị ka data ọha na eze si kwuo, n'ọhịa nke chemiluminescence immunodiagnosis na China, a rụpụtawo nsonaazụ dị mma na mpaghara nke ọkara na obere njedebe immunodiagnosis. Otú ọ dị, n'ahịa chemiluminescence dị elu nke China, ndị na-emepụta ihe na-ebubata ka na-eji ihe karịrị 80% nke ahịa ahịa. N'ime ha, Abbott, Roche, Beckman na Siemens bụ ihe dịka 70% nke oke ahịa. Otú ọ dị, site na mmelite nke ọkwa oriri ahụike nke China, nkwalite usoro ọgwụgwọ ahụike na nkwado siri ike nke iwu ụlọ ọrụ mmepụta ihe nke mba, anyị na-elekwasị anya na mmepe nke reagents nchọpụta in vitro, ma nwee olileanya ịkwado gị.